Furthermore, the AR may contribute to the growth of other malignancies, such as breast cancer, hepatocellular carcinoma and ovarian cancer, with ongoing clinical trials targeting the AR in patients bearing these cancers [12]. This evidence concerns the gene AR and breast cancer.